Both the Pfizer-BioNtech and Oxford-AstraZeneca shots associated with markedly reducing the risk of hospitalization for COVID-19, preliminary findings from Scotland suggest.
Related
Why we need to rethink COVID-19 risk as the weather warms up
Experts say we need to shift our messaging and set out realistic parameters for socializing safely over the next few months or risk losing the room — or worse, pushing people to more dangerous behaviour.
Why AstraZeneca vaccine approval in Canada may open more doors
Health Canada's approval of the Oxford-AstraZeneca vaccine to prevent COVID-19 in adults follows similar green lights from regulators worldwide.
The human side of healing: How seeing loved ones helps COVID-19 patients
COVID-19 restrictions are keeping many patients isolated in the hospital, but a new study is highlighting what doctors, patients and families have seen: being near loved ones can play a role in healing — specifically around a common brain dysfunction that comes with COVID-19.